We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZINGU
6801
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
-100,000
Closed -$1M
AFTR.U
6802
DELISTED
AfterNext HealthTech Acquisition Corp Units
AFTR.U
-99,900
Closed -$979K
CPAAU
6803
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
-142,302
Closed -$1.41M
TLGA.U
6804
DELISTED
TLG Acquisition One Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TLGA.U
-1
Closed
HGEN
6805
DELISTED
HUMANIGEN, INC.
HGEN
$0 ﹤0.01%
69
-23,094
-100% -$51.8K
NMTR
6806
DELISTED
9 Meters Biopharma
NMTR
$0 ﹤0.01%
8
-5,309
-100% -$50K
VBOCU
6807
DELISTED
Viscogliosi Brothers Acquisition Corp Unit
VBOCU
-86,255
Closed -$858K
FACT.U
6808
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
-150,000
Closed -$1.48M
TESS
6809
DELISTED
Tessco Technologies Inc
TESS
$0 ﹤0.01%
7
TTCF
6810
PUT
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
-43,800
Closed -$551K
TCFC
6811
DELISTED
The Community Financial Corporation Common Stock
TCFC
$0 ﹤0.01%
6
-838
-99% -$31.8K
XM
6812
PUT
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-230,000
Closed -$6.57M
STCN
6813
DELISTED
Steel Connect, Inc. Common Stock
STCN
$0 ﹤0.01%
1
-3
-75% -$36
LITTU
6814
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
-50,000
Closed -$492K
FNCH
6815
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-118
Closed -$18K
MTVC.U
6816
DELISTED
Motive Capital Corp II Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
MTVC.U
-252,872
Closed -$2.58M
ACOR
6817
DELISTED
Acorda Therapeutics
ACOR
$0 ﹤0.01%
+1
New +$18
MNTV
6818
PUT
DELISTED
Momentive Global Inc. Common Stock
MNTV
-60,000
Closed -$976K
SGTX
6819
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-7,752
Closed -$148K
BIOC
6820
DELISTED
Biocept, Inc.
BIOC
-2,712
Closed -$189K
VLAT
6821
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
-157,332
Closed -$1.53M
OSH
6822
PUT
DELISTED
Oak Street Health, Inc.
OSH
-3,600
Closed -$97K
TRAQ.U
6823
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
-100,129
Closed -$1.01M
LMST
6824
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$0 ﹤0.01%
8
SKYAU
6825
DELISTED
Skydeck Acquisition Corp. Units
SKYAU
-151,112
Closed -$1.49M

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.